Connecting the Dots in Early Drug Discovery at Novartis

02 Nov, 2016

We have created a large Neo4J database that integrates the results from textmining, experimental data, and biological background knowledge. The utility of this graph is twofold: 1.Identify promising compounds to be tested as a starting point for drug development. 2. Better understand the results of large scale compound testing in cellular assays using imaging technology. STEPHAN REILING, SENIOR SCIENTIST, NOVARTIS

Related Videos